We are live on !
Find out more
Scale Management Portfolio holdings
AUM
$359M
This Fund
S&P 500
This Quarter Est. Return
+29.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$25.1M
(+14%)
Cap. Flow
-$10.8M
Cap. Flow % of AUM
Cap. Flow %
-5.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
–
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.3
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.06M |
| 2 |
RingCentral
RNG
|
+$875K |
| 3 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$826K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.98% |
| 2 | Technology | 44.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
HubSpot
HUBS
$10.5B
| $68.7M | 34.3% |
1,721,075
| – | – |
2014 Q4
1 quarter
|
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $44.4M | 22.19% |
1,710,451
-494,112
| -22% | -$9.06M |
2014 Q4
1 quarter
|
|
3
DELISTED
Alimera Sciences
ALIM
| $22.8M | 11.41% |
303,899
| – | – |
2014 Q4
1 quarter
|
|
|
OREX
4
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $22.6M | 11.28% |
288,431
-13,314
| -4% | -$826K |
2014 Q4
1 quarter
|
|
|
EVDY
5
DELISTED
Everyday Health, Inc.
EVDY
| $22.2M | 11.1% |
1,727,632
| – | – |
2014 Q4
1 quarter
|
|
|
6
RingCentral
RNG
$6.34B
| $19.5M | 9.72% |
1,269,568
-58,120
| -4% | -$875K |
2014 Q4
1 quarter
|
|
Similar funds
AWW
MCM
Scale Management's Q1 2015 Portfolio in Review
As of Q1 2015, Scale Management held 6 positions worth $200M, up 14% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Scale Management withdrew a net $10.8M in Q1 2015, reducing 3 holdings. Its largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $9.06M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 56% a quarter earlier, followed by Technology.
- Scale Management's biggest Q1 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $9.06M.
- Scale Management's ten largest holdings make up 100% of its $200M portfolio in Q1 2015.
- Scale Management opened 0 new positions and closed 0 in Q1 2015.
- Scale Management's portfolio value rose 14% quarter-over-quarter to $200M.
Based on Scale Management's 13F filing for Q1 2015, filed 2 Jun 2015.